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Determinants of medium and high VACS index in HIV-positive
patients on effective HAART
Suardi, E; Gazzola, L; Cicconi, P; Grillo, E; Bini, T; Marchetti, G and d’Arminio Monforte, A
San Paolo Hospital, Institute of Infectious and Tropical Diseases, Dep. Health and Sciences, University of Milan, Milan, Italy.
Non-AIDS events are the leading cause of death in HIV-positive patients (pts) on effective HAART.The VACS index, composed by
HIV-RNA, CD4, age, hemoglobin, FIB-4, eGFR and HCV co-infection, has been validated as 5-year mortality index in HIV-
positive pts [1]. The aim of our study was to evaluate the prevalence and any possible predictive factors of medium-high VACS
index in a cohort of HIV-positive pts; we also evaluated whether it relates with markers of systemic immune activation. 501
consecutive HIV-positive asymptomatic pts on effective HAART (HIV-RNA B40 cp/ml) were enrolled. T-cell activation (CD38,
CD845R0, CD838R0) and differentiation (CD127) was assessed by flow cytometry; VACS index was calculated closest to
the sample timepoint. Comparisons were assessed by Chi-square test. Factors associated with VACS index equal or greater than
10% (gender, time on HAART, CD4nadir, AIDS diagnosis, previous or current IDU, immune-activation markers) in univariate
model entered the multivariate logistic regression. Of the 501 patients enrolled, 350 (70%) had a low VACS index (VACS B10%),
143 (28%) a medium index (VACS 1030%) and 8 (1%) an high one (VACS  30%). Groups (pts with low and medium-high VACS
index) were comparable for CD4 nadir, AIDS diagnosis, CD845RO%, CD838RO%, CD127%. Females, active or previous
IDU, pts with shorter HAART exposure showed more frequently medium-high VACS index (table 1). In the multivariable model,
female sex (AOR 6.26, 95% CI 3.45-11.38, pB0.000), IDU history (AOR 2.409, 95% CI 1.314.422, p0.0045) and current
CD38/CD8% (each% more: AOR 1.122, 95% CI 1.03-1.21, p0.004) were all independent predictors of VACS ]10%. Our data
suggest that a persistently-activated immune profile despite virologically-suppressive HAART may contribute to all-cause
mortality risk, possibly through its role in accelerating degenerative disease. Possible determinants of gender differences in VACS
index (such as hemoglobin) need to be further studied.
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Table 1. Variable associated with medium-high VACS index in univariate model
Pts with low (B10%) VACS index (n350) Pts with medium-high ( 10%) VACS index (n151) p
Female sex 8 69 (19%) 66 (43%) 0.0001
AIDS8 75 (21%) 50 (33%) 0.38
Nadir CD4 T cells/mmc* 211 (7600) 183 (4489) 0.75
HAART duration, years* 8.1 (121) 7.9 (120) 0.01
IDU8 74 (21%) 50 (33%) 0.004
CD127/CD4%* 35 (063) 35 (058) 0.81
CD127/CD8%* 44 (055) 45 (046) 0.70
CD845/RO%* 13 (043) 14 (061) 0.7
CD838/RO%* 1,5 (027) 1,6 (013) 0.85
CD8CD38%* 3.01 (023) 4.09 (023) 0.004
*Data are presented as mean (range)
8Data are presented as the number (percentage)
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